As of 2026-10-04, the Relative Valuation of PTC Therapeutics Inc (PTCT) is 50.88 USD. This relative valuation is based on P/E multiples. With the latest stock price at 63.46 USD, the upside of PTC Therapeutics Inc based on Relative Valuation is -19.8%.
The range of the Relative Valuation is (11.91) - 116.33 USD.
| Range | Selected | |
| Trailing P/E multiples | 25.7x - 30.3x | 29.1x |
| Forward P/E multiples | 24.8x - 25.2x | 25.0x |
| Fair Price | (11.91) - 116.33 | 50.88 |
| Upside | -118.8% - 83.3% | -19.8% |
| Date | P/E |
| 2026-10-02 | -137.15 |
| 2026-10-01 | -138.60 |
| 2026-09-30 | -140.00 |
| 2026-09-29 | -140.39 |
| 2026-09-28 | -142.53 |
| 2026-09-25 | -135.44 |
| 2026-09-24 | -134.60 |
| 2026-09-23 | -134.73 |
| 2026-09-22 | -142.55 |
| 2026-09-21 | -141.04 |
| 2026-09-18 | -141.28 |
| 2026-09-17 | -146.96 |
| 2026-09-16 | -146.07 |
| 2026-09-15 | -141.88 |
| 2026-09-14 | -143.67 |
| 2026-09-11 | -142.77 |
| 2026-09-10 | -145.60 |
| 2026-09-09 | -146.03 |
| 2026-09-08 | -148.71 |
| 2026-09-04 | -149.77 |
| 2026-09-03 | -154.31 |
| 2026-09-02 | -155.15 |
| 2026-09-01 | -152.49 |
| 2026-08-31 | -150.29 |
| 2026-08-28 | -151.48 |
| 2026-08-27 | -155.19 |
| 2026-08-26 | -157.10 |
| 2026-08-25 | -158.78 |
| 2026-08-24 | -153.57 |
| 2026-08-21 | -150.89 |
| 2026-08-20 | -152.41 |
| 2026-08-19 | -159.21 |
| 2026-08-18 | -156.97 |
| 2026-08-17 | -157.51 |
| 2026-08-14 | -154.96 |
| 2026-08-13 | -155.54 |
| 2026-08-12 | -156.99 |
| 2026-08-11 | -159.28 |
| 2026-08-10 | -161.29 |
| 2026-08-07 | -158.44 |
| 2026-08-06 | -153.12 |
| 2026-08-05 | -149.57 |
| 2026-08-04 | -149.34 |
| 2026-08-03 | -147.21 |
| 2026-07-31 | -146.98 |
| 2026-07-30 | -163.21 |
| 2026-07-29 | -160.99 |
| 2026-07-28 | -162.93 |
| 2026-07-27 | -163.82 |
| 2026-07-24 | -166.02 |